Literature DB >> 10334473

Effect of vitamin E on chromosomal aberrations in lymphocytes from patients with Down's syndrome.

J Pincheira1, M H Navarrete, C de la Torre, G Tapia, M J Santos.   

Abstract

A possible protective effect of vitamin E (DL-alpha-tocopherol) on chromosomal damage was evaluated in lymphocytes from patients with Down's syndrome (DS) and from controls. This included the analysis of the basal and G2 chromosomal aberration frequencies in lymphocytes cultured with and without 100 microM vitamin E. The chromosomal damage in G2 was determined by scoring the number of chromosomal aberrations in lymphocyte cultures treated with 5 mM caffeine, 2 h before harvesting. Vitamin E treatment decreased the basal and G2 chromosomal aberrations both in control and DS lymphocytes. In DS cells, this protective effect, expressed as a decrease in the chromosomal damage, was greater (50%) than in controls (30%). These results suggest that the increment in basal and G2 aberrations yield in DS lymphocytes may be related to the increase in oxidative damage reported in these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334473     DOI: 10.1034/j.1399-0004.1999.550307.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Levels of non enzymatic antioxidants in Down syndrome.

Authors:  S Mehar Sulthana; S Nandha Kumar; M G Sridhar; B Vishnu Bhat; K Ramachandra Rao
Journal:  Indian J Pediatr       Date:  2012-06-08       Impact factor: 1.967

Review 2.  Neurologic complications of Down syndrome: a systematic review.

Authors:  Jonathan D Santoro; Dania Pagarkar; Duong T Chu; Mattia Rosso; Kelli C Paulsen; Pat Levitt; Michael S Rafii
Journal:  J Neurol       Date:  2020-09-12       Impact factor: 6.682

3.  The Vitamin E Analog Gamma-Tocotrienol (GT3) Suppresses Radiation-Induced Cytogenetic Damage.

Authors:  Rupak Pathak; Abdel Bachri; Sanchita P Ghosh; Igor Koturbash; Marjan Boerma; Regina K Binz; Jeffrey R Sawyer; Martin Hauer-Jensen
Journal:  Pharm Res       Date:  2016-05-23       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.